10xDNA Capital Partners
10xDNA Capital Partners is a company.
Active
Updated: ·
About
10xDNA Capital Partners is a company.
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at 10xDNA Capital Partners.
10xDNA Capital Partners is a company.
10xDNA Capital Partners is a company.
Key people at 10xDNA Capital Partners.
Key people at 10xDNA Capital Partners.
10xDNA Capital Partners is a Germany-based investment fund specializing in public companies within disruptive technologies, including AI, biotech, 3D printing, and robotics.[1] Its mission centers on forward-looking investments in transformative tech, exemplified by its Small & Midcap Fund holdings in 3D printing firms like Markforged, Norsk Titanium, and Xometry, while maintaining ties to venture capital roots.[1] The firm's investment philosophy emphasizes dynamic portfolio adjustments to capitalize on macrotrends like reshoring and software-centric shifts in manufacturing, distinguishing it from rigid ETFs through broad tech expertise and agility from its smaller fund size.[1]
10xDNA impacts the startup ecosystem indirectly via its VC heritage and focus on scaling public tech firms, bridging early-stage innovation with public markets to support growth in high-potential sectors.[1][2]
10xDNA Capital Partners was spun out from Freigeist Capital three years prior to mid-2020 (around 2017), founded by Frank Thelen, a prominent tech investor and serial founder known from Germany's *Die Höhle der Löwen* (Dragons' Den).[1] Freigeist Capital, established by Thelen, concentrates on seed funding for unique startups, while 10xDNA shifted focus to public market investments in tech disruptors, retaining strong connections to its VC parent.[1][2] Key figures include Senior Research Analyst Paul Schmidt, who covers manufacturing and 3D printing, and Thelen, who shares insights on trends via his "Innovation Pulse" newsletter covering Freigeist and 10xDNA topics.[1][2] The evolution reflects a strategic pivot from early-stage VC to public equities amid rising tech-focused funds, advised potentially through entities like TEQ Capital GmbH in Bonn, which handles tech sector investments.[3]
10xDNA rides the wave of disruptive tech convergence, including AI, biotech, robotics, and advanced manufacturing like 3D printing, where timing investments amid rapid advancements is critical.[1] The timing aligns with market forces like reshoring production, labor shortages, and the pivot from hardware to software-driven 3D printing models, which the firm views as growth catalysts despite cyclical challenges.[1] By focusing on public markets post-VC spinout, 10xDNA influences the ecosystem by providing liquidity and visibility to scaling tech firms, amplifying European innovation in global trends and complementing seed funders like Freigeist.[1][2]
10xDNA is poised to expand in software-centric additive manufacturing and broader tech disruptions, capitalizing on reshoring and AI integration for outsized returns in its nimble Small & Midcap Fund.[1] Trends like geopolitical supply chain shifts and tech convergence will shape its path, potentially growing influence through deeper VC-public market synergies under Frank Thelen's vision.[1][2] As public tech investments evolve, 10xDNA's agile, expertise-driven approach positions it to bridge tomorrow's disruptions, echoing its origins in spotting high-potential innovators.
